Withanone Ameliorates Stress Symptoms in Caenorhabditis Elegans by Acting through Serotonin Receptors

ABSTRACT

Introduction Depression is responsible for 800 000 deaths worldwide, a number that will rise significantly due to the COVID-19 pandemic. Affordable novel drugs with less severe side effects are urgently required. We investigated the effect of withanone (WN) from Withania somnifera on the serotonin system of wild-type and knockout Caenorhabditis elegans strains using in silico, in vitro, and in vivo methods.

Methods WN or fluoxetine (as positive control drug) was administered to wild-type (N2) and knockout C. elegans strains (AQ866, DA1814, DA2100, DA2109, and MT9772) to determine their effect on oxidative stress (Trolox, H₂DCFDA, and juglone assays) on osmotic stress and heat stress and lifespan. Quantitative real-time RT-PCR was applied to investigate the effect of WN or fluoxetine on the expression of serotonin receptors (ser-1, ser-4, ser-7) and serotonin transporter (mod-5). The binding affinity of WN to serotonin receptors and transporter was analyzed in silico using AutoDock 4.2.6.

Results WN scavenged ROS in wild-type and knockout C. elegans and prolonged their lifespan. WN upregulated the expression of serotonin receptor and transporter genes. In silico analyses revealed high binding affinities of WN to Ser-1, Ser-4, Ser-7, and Mod-5.

Limitations Further studies are needed to prove whether the results from C. elegans are transferrable to mammals and human beings.

Conclusion WN ameliorated depressive-associated stress symptoms by activating the serotonin system. WN may serve as potential candidate in developing new drugs to treat depression.

Key words

Caenorhabditis elegans - depression - lifespan - molecular docking - stress

Publication History

Article published online:
06 May 2021

• References

• 1 World Health Organization. Depression and other common mental disorders: Global health estimates; 2017; https://apps.who.int/iris/handle/10665/254610 Accessed on February 19, 2021
• 2 Kanter JMK. COVID-19 could lead to an epidemic of clinical depression, and the health care system isn’t ready for that, either. 2020; https://theconversation.com/covid-19-could-lead-to-an-epidemic-of-clinical-depression-and-the-health-care-system-isnt-ready-for-that-either-134528. Accessed on February 19, 2021
• 3 Zhang Y, Chen Y, Ma L. Depression and cardiovascular disease in elderly: Current understanding. J Clin Neurosci 2018; 47: 1-5
• 4 Rivera M, Porras-Segovia A, Rovira P. et al. Associations of major depressive disorder with chronic physical conditions, obesity and medication use: Results from the PISMA-ep study. Eur Psychiatry 2019; 60: 20-27
• 5 Crawford AA, Lewis S, Nutt D. et al. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals. Psychopharmacology (Berl) 2014; 231: 2921-2931
• 6 Bellivier F, Henry C, Szöke A. et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett 1998; 255: 143-146
• 7 Yuan H, Zhu X, Luo Q. et al. Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study. Neuropsychiatr Dis Treat 2019; 15: 957-966
• 8 Li J, OW Li W. et al. Oxidative stress and neurodegenerative disorders. Int J Mol Sci 2013; 14: 24438-24475
• 9 Angelova PR, Abramov AY. Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett 2018; 592: 692-702
• 10 Wadhwa R, Gupta R, Maurya PK. Oxidative stress and accelerated aging in neurodegenerative and neuropsychiatric disorder. Curr Pharm Des 2018; 24: 4711-4725
• 11 Chung CP, Schmidt D, Stein CM. et al. Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res 2013; 206: 213-216
• 12 Maes M, Kubera M, Mihaylova I. et al. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J Affect Disord 2013; 149: 23-29
• 13 Sperner-Unterweger B, Kohl C, Fuchs D. Immune changes and neurotransmitters: Possible interactions in depression?. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48: 268-276
• 14 Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902
• 15 Liu L, Liu C, Wang Y. et al. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol 2015; 13: 481-493
• 16 Wang Y, Li M, Liang Y. et al. Chinese herbal medicine for the treatment of depression: Applications, efficacies and mechanisms. Curr Pharm Des 2017; 23: 5180-5190
• 17 Sarris J, Panossian A, Schweitzer I. et al. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 2011; 21: 841-860
• 18 Ren Y, Zhu C, Wu J. et al. Comparison between herbal medicine and fluoxetine for depression: a systematic review of randomized controlled trials. Complement Ther Med 2015; 23: 674-684
• 19 Ismail H, Amanat MA, Iqbal A. et al. Medicinal plants: A complementary and alternative antidepressant therapy. Curr Pharm Des 2018; 24: 2609-2624
• 20 Singh N, Bhalla M, Jager Pde. et al. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 2011; 8: 208-213
• 21 Konar A, Shah N, Singh R. et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 2011; 6: e27265
• 22 Panossian A, Seo EJ, Efferth T. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells. Phytomedicine 2019; 60: 152881
• 23 Garg S, Kaul SC, Wadhwa R. Anti-stress and glial differentiation effects of a novel combination of cucurbitacin B and withanone (CucWi-N): Experimental evidence. Ann Neurosci 2018; 25: 201-209
• 24 Kaletta T, Hengartner MO. Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 2006; 5: 387-398
• 25 Rodriguez M, Snoek LB, Bono Mde. et al. Worms under stress: C. elegans stress response and its relevance to complex human disease and aging. Trends Genet 2013; 29: 367-374
• 26 Ding X, Njus Z, Kong T. et al. Effective drug combination for Caenorhabditis elegans nematodes discovered by output-driven feedback system control technique. Sci Adv 2017; 3: eaao1254
• 27 O’Reilly LP, Luke CJ, Perlmutter DH. et al. C. elegans in high-throughput drug discovery. Adv Drug Deliv Rev 2014; 69-70: 247-453
• 28 Ni YG, Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94: 2036-2040
• 29 Zafir A, Banu N. Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 2007; 572: 23-31
• 30 Girard LR, Fiedler TJ, Harris TW. et al. WormBook: The online review of Caenorhabditis elegans biology. Nucleic Acids Res 2007; 35: D472-D475
• 31 Strange K. An overview of C. elegans biology. Methods Mol Biol 2006; 351: 1-11
• 32 Wongchai K, Schlotterer A, Lin J. et al. Protective effects of liraglutide and linagliptin in C. elegans as a new model for glucose-induced neurodegeneration. Horm Metab Res 2016; 48: 70-75
• 33 Miller NJ, Rice-Evans C, Davies MJ. et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-412
• 34 Naß J, Efferth T. Ursolic acid ameliorates stress and reactive oxygen species in C. elegans knockout mutants by the dopamine Dop1 and Dop3 receptors. Phytomedicine 2021; 81: 153439
• 35 Naß J, Abdelfatah S, Efferth T. Ursolic acid enhances stress resistance, reduces ROS accumulation and prolongs life span in C. elegans serotonin-deficient mutants. Food Funct 2021; https://doi.org/10.1039/d0fo02208j; PMID: 33596295
• 36 Naß J, Abdelfatah S, Efferth T. Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A. Phytomedicine. 2021; 84: 153482
• 37 Solomon A, Bandhakavi S, Jabbar S. et al. Caenorhabditis elegans OSR-1 regulates behavioral and physiological responses to hyperosmotic environments. Genetics 2004; 167: 161-170
• 38 Zevian SC, Yanowitz JL. Methodological considerations for heat shock of the nematode Caenorhabditis elegans. Methods 2014; 68: 450-457
• 39 Sutphin GL, Kaeberlein M. Measuring Caenorhabditis elegans life span on solid media. J Vis Exp 2009; 27: 1152
• 40 Zhang Y, Chen D, Smith MA. et al. Selection of reliable reference genes in Caenorhabditis elegans for analysis of nanotoxicity. PLoS One 2012; 7: e31849
• 41 Kiefer F, Arnold K, Künzli M. et al. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res 2009; 37: D387-D392
• 42 Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol 2015; 1263: 243-250
• 43 Morris GM, Huey R, Lindstrom W. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785-2791
• 44 Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 1: 33-38
• 45 Kadioglu O, Saeed ME, Valoti M. et al. Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses. Biochem Pharmacol 2016; 104: 42-51
• 46 Han SK, Lee D, Lee H. et al. OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research. Oncotarget 2016; 7: 56147-56152
• 47 GraphPad Prism. La Jolla California USA 2020 Available from URL www.graphpad.com
• 48 Huether G, Fettkötter I, Keilhoff G. et al. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. J Neurochem 1997; 69: 2096-2101
• 49 Lv J, Liu F. The role of serotonin beyond the central nervous system during embryogenesis. Front Cell Neurosci 2017; 11: 74
• 50 Herr N, Bode C, Duerschmied D. The effects of serotonin in immune cells. Front Cardiovasc Med 2017; 4: 48i https://doi.org/10.3389/fcvm.2017.00048
• 51 Dar NJ, Bhat JA, Satti NK. et al. Withanone, an active constituent from Withania somnifera, affords protection against NMDA-induced excitotoxicity in neuron-like cells. Mol Neurobiol 2017; 54: 5061-5073 https://doi.org/10.1007/s12035-016-0044-7; PMID: 27541286
• 52 Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 1997; 35: 236-239 PMID: 9332168
• 53 Ahmad T, Suzuki YJ. Juglone in oxidative stress and cell signaling. Antioxidants (Basel) 2019; 8: 91
• 54 Hukema RK, Rademakers S, Jansen G. Gustatory plasticity in C. elegans involves integration of negative cues and NaCl taste mediated by serotonin, dopamine, and glutamate. Learn Mem 2008; 15: 829-836
• 55 Martinière A, Fiche JB, Smokvarska M. et al. Osmotic stress activates two reactive oxygen species pathways with distinct effects on protein nanodomains and diffusion. Plant Physiol 2019; 179: 1581-1593
• 56 Tatum MC, Ooi FK, Chikka MR. et al. Neuronal serotonin release triggers the heat shock response in C. elegans in the absence of temperature increase. Curr Biol 2015; 25: 163-174
• 57 Slimen IB, Najar T, Ghram A. et al. Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia 2014; 30: 513-523
• 58 Yu Y-B, Dosanjh L, Lao L. et al. Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways. PLoS One 2010; 5: e9339
• 59 Murakami H, Murakami S. Serotonin receptors antagonistically modulate Caenorhabditis elegans longevity. Aging Cell 2007; 6: 483-488
• 60 Nikiforuk A. Targeting the Serotonin 5-HT7 Receptor in the search for treatments for CNS disorders: Rationale and progress to date. CNS Drugs 2015; 29: 265-275
• 61 Petrascheck M, Ye X, Buck LB. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 2007; 450: 553-556
• 62 Kumar R, Gupta K, Saharia K. et al. Withania somnifera root extract extends lifespan of Caenorhabditis elegans. Ann Neurosci 2013; 20: 13-16
• 63 Larsen PL. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci USA 1993; 90: 8905-8909
• 64 Wang H, Liu J, Li T. et al. Blueberry extract promotes longevity and stress tolerance via DAF-16 in Caenorhabditis elegans. Food Funct 2018; 9: 5273-5282 https://doi.org/10.1039/c8fo01680a
• 65 Wiegant FA, Surinova S, Ytsma E. et al. Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology 2009; 10: 27-42